DETECTION AND MANAGEMENT
of hepatitis C in the US prison population is a major public health problem, as evidenced by the estimate that more than one third1 of the approximately 5,400,000 people in the United States with active hepatitis C enter correctional facilities yearly.2 In North Dakota (popu- lation 642 000), the true inci- dence and prevalence of hepatitis C is not known; however, 25% of all positive antibody tests for hepatitis C reported yearly by the North Dakota Department of Health originate from the North Dakota Department of Correc- tions and Rehabilitation (ND DOCR). Hepatitis C in prison populations is now a major public health problem, and large numbers of correctional facilities have no comprehensive management program, often because of formi- dable projected costs and tightening budget constraints. The North Dakota Department of Corrections and Rehabilitation has operated a management and therapy program since 2002 using consensus interferon and ribavirin with 45% cost savings. The program has provided excellent sustained viral responses: 54.2% for genotype 1 hepatitis C, 75% for genotypes 2 and 3, and 63.6% overall. (Am J Public Health. 2010;100:13–17. doi: 10.2105/AJPH.2008.147629.) Prisoners can be screened and educated captive audience
That does the vaccination of inmates is recommended to prevent transmission of infectious diseases in correctional facilities and previously incarcerated people before they return to the community
The Texas Department of correctional study indicated that rates of vaccine acceptace instead vaccine series completion among inmates were high establishing hepatitis vaccination programs in prisons and jails can prevent a substantial proportion of hepatitis infections among adults in the outside community
evaluation of the Texas Department of Corrections study demonstrated that high...